Skip to main content
Erschienen in: Oral Radiology 3/2017

09.12.2016 | Original Article

Effects of dose rate on early and late complications in low dose rate brachytherapy for mobile tongue carcinoma using 192Ir sources

verfasst von: Atsushi Kaida, Hiroshi Watanabe, Kazuma Toda, Keiko Yuasa-Nakagawa, Ryoichi Yoshimura, Masahiko Miura

Erschienen in: Oral Radiology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Low dose rate brachytherapy using 192Ir sources (LDR-BRT) is the definitive radiotherapy for early stage mobile tongue carcinoma. The effects of dose rate on early and late complications require re-evaluation, because the prescribed dose is almost fixed and a spacer has recently been used in all cases. Given this situation, we investigated any adverse effects of dose rate in LDR-BRT.

Methods

For this retrospective study, 116 patients with early tongue cancer treated with LDR-BRT alone at Tokyo Medical and Dental University Medical Hospital between 2008 and 2013 were enrolled. The patients were classified into two groups according to dose rate or biological effective dose. All patients had a spacer in place throughout the treatment period.

Results

The rates of overall survival, local control, and neck node metastasis did not differ significantly between the two groups. Notably, there were no significant differences in the severity or incidence of early or late complications between the two groups.

Conclusions

In the present study, we demonstrated that a dose rate of up to 0.91 Gy/h did not significantly influence the incidence of early or late complications when other factors were well controlled in the presence of a spacer.
Literatur
1.
Zurück zum Zitat Shibuya H, Hoshina M, Takeda M, Matsumoto S, Suzuki S, Okada N. Brachytherapy for stage I & II oral tongue cancer: an analysis of past cases focusing on control and complications. Int J Radiat Oncol Biol Phys. 1993;26:51–8.CrossRefPubMed Shibuya H, Hoshina M, Takeda M, Matsumoto S, Suzuki S, Okada N. Brachytherapy for stage I & II oral tongue cancer: an analysis of past cases focusing on control and complications. Int J Radiat Oncol Biol Phys. 1993;26:51–8.CrossRefPubMed
2.
Zurück zum Zitat Mazeron JJ, Crook JM, Marinello G, Walop W, Pierquin B. Prognostic factors of local outcome for T1, T2 carcinomas of oral tongue treated by iridium 192 implantation. Int J Radiat Oncol Biol Phys. 1990;19:281–5.CrossRefPubMed Mazeron JJ, Crook JM, Marinello G, Walop W, Pierquin B. Prognostic factors of local outcome for T1, T2 carcinomas of oral tongue treated by iridium 192 implantation. Int J Radiat Oncol Biol Phys. 1990;19:281–5.CrossRefPubMed
3.
Zurück zum Zitat Bourgier C, Coche-Déquéant B, Fournier C, Castelain B, Prévost B, Lefebvre JL, et al. Exclusive low-dose-rate brachytherapy in 279 patients with T2N0 mobile tongue carcinoma. Int J Radiat Oncol Biol Phys. 2005;63:434–40.CrossRefPubMed Bourgier C, Coche-Déquéant B, Fournier C, Castelain B, Prévost B, Lefebvre JL, et al. Exclusive low-dose-rate brachytherapy in 279 patients with T2N0 mobile tongue carcinoma. Int J Radiat Oncol Biol Phys. 2005;63:434–40.CrossRefPubMed
4.
Zurück zum Zitat Wadsley JC, Patel M, Tomlins CD, Gildersleve JQ. Iridium-192 implantation for T1 and T2a carcinoma of the tongue and floor of mouth: retrospective study of the results of treatment at the Royal Berkshire Hospital. Br J Radiol. 2003;76:414–7.CrossRefPubMed Wadsley JC, Patel M, Tomlins CD, Gildersleve JQ. Iridium-192 implantation for T1 and T2a carcinoma of the tongue and floor of mouth: retrospective study of the results of treatment at the Royal Berkshire Hospital. Br J Radiol. 2003;76:414–7.CrossRefPubMed
5.
Zurück zum Zitat Bachaud JM, Delannes M, Allouache N, Benchalal M, Alzieu C, David JM, et al. Radiotherapy of stage I and II carcinomas of the mobile tongue and/or floor of the mouth. Radiother Oncol. 1994;31:199–206.CrossRefPubMed Bachaud JM, Delannes M, Allouache N, Benchalal M, Alzieu C, David JM, et al. Radiotherapy of stage I and II carcinomas of the mobile tongue and/or floor of the mouth. Radiother Oncol. 1994;31:199–206.CrossRefPubMed
6.
Zurück zum Zitat Oota S, Shibuya H, Yoshimura R, Watanabe H, Miura M. Brachytherapy of stage II mobile tongue carcinoma. Prediction of local control and QOL. Radiat Oncol. 2006;1:21.CrossRefPubMedPubMedCentral Oota S, Shibuya H, Yoshimura R, Watanabe H, Miura M. Brachytherapy of stage II mobile tongue carcinoma. Prediction of local control and QOL. Radiat Oncol. 2006;1:21.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Yoshimura R, Shibuya H, Miura M, Watanabe H, Ayukawa F, Hayashi K, et al. Quality of life of oral cancer patients after low-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2009;73:772–8.CrossRefPubMed Yoshimura R, Shibuya H, Miura M, Watanabe H, Ayukawa F, Hayashi K, et al. Quality of life of oral cancer patients after low-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2009;73:772–8.CrossRefPubMed
8.
Zurück zum Zitat Curi MM, Oliveira dos Santos M, Feher O, Faria JC, Rodrigues ML, Kowalski LP. Management of extensive osteoradionecrosis of the mandible with radical resection and immediate microvascular reconstruction. J Oral Maxillofac Surg. 2007;65:434–8.CrossRefPubMed Curi MM, Oliveira dos Santos M, Feher O, Faria JC, Rodrigues ML, Kowalski LP. Management of extensive osteoradionecrosis of the mandible with radical resection and immediate microvascular reconstruction. J Oral Maxillofac Surg. 2007;65:434–8.CrossRefPubMed
9.
Zurück zum Zitat Lozza L, Cerrotta A, Gardani G, De Marie M, Di Russo A, Kenda R, et al. Analysis of risk factors for mandibular bone radionecrosis after exclusive low dose-rate brachytherapy for oral cancer. Radiother Oncol. 1997;44:143–7.CrossRefPubMed Lozza L, Cerrotta A, Gardani G, De Marie M, Di Russo A, Kenda R, et al. Analysis of risk factors for mandibular bone radionecrosis after exclusive low dose-rate brachytherapy for oral cancer. Radiother Oncol. 1997;44:143–7.CrossRefPubMed
10.
Zurück zum Zitat Mazeron JJ, Simon JM, Le Péchoux C, Crook JM, Grimard L, Piedbois P, et al. Effect of dose rate on local control and complications in definitive irradiation of T1-2 squamous cell carcinomas of mobile tongue and floor of mouth with interstitial iridium-192. Radiother Oncol. 1991;21:39–47.CrossRefPubMed Mazeron JJ, Simon JM, Le Péchoux C, Crook JM, Grimard L, Piedbois P, et al. Effect of dose rate on local control and complications in definitive irradiation of T1-2 squamous cell carcinomas of mobile tongue and floor of mouth with interstitial iridium-192. Radiother Oncol. 1991;21:39–47.CrossRefPubMed
11.
Zurück zum Zitat Hall EJ, Giaccia J. Fractionated radiation and the dose-rate effect. In: Hall EJ, Giaccia J, editors. Radiobiology for the radiologist. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2012. p. 67–85. Hall EJ, Giaccia J. Fractionated radiation and the dose-rate effect. In: Hall EJ, Giaccia J, editors. Radiobiology for the radiologist. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2012. p. 67–85.
12.
Zurück zum Zitat Hall EJ, Giaccia J. Cell survival curves. In: Hall EJ, Giaccia J, editors. Radiobiology for the radiologist. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2012. p. 35–53. Hall EJ, Giaccia J. Cell survival curves. In: Hall EJ, Giaccia J, editors. Radiobiology for the radiologist. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2012. p. 35–53.
13.
Zurück zum Zitat Miura M, Takeda M, Sasaki T, Inoue T, Nakayama T, Fukuda H, et al. Factors affecting mandibular complications in low dose rate brachytherapy for oral tongue carcinoma with special reference to spacer. Int J Radiat Oncol Biol Phys. 1998;41:763–70.CrossRefPubMed Miura M, Takeda M, Sasaki T, Inoue T, Nakayama T, Fukuda H, et al. Factors affecting mandibular complications in low dose rate brachytherapy for oral tongue carcinoma with special reference to spacer. Int J Radiat Oncol Biol Phys. 1998;41:763–70.CrossRefPubMed
14.
Zurück zum Zitat Fujita M, Tamamoto M, Hirokawa Y, Kashiwado K, Akagi Y, Kashimoto K, et al. Experimental and clinical studies on dose reduction effects of spacers in interstitial brachytherapy for carcinoma of the mobile tongue. Oral Surg Oral Med Oral Pathol. 1993;76:797–803.CrossRefPubMed Fujita M, Tamamoto M, Hirokawa Y, Kashiwado K, Akagi Y, Kashimoto K, et al. Experimental and clinical studies on dose reduction effects of spacers in interstitial brachytherapy for carcinoma of the mobile tongue. Oral Surg Oral Med Oral Pathol. 1993;76:797–803.CrossRefPubMed
15.
Zurück zum Zitat Obinata K, Ohmori K, Tuchiya K, Nishioka T, Shirato H, Nakamura M. Clinical study of a spacer to help prevent osteoradionecrosis resulting from brachytherapy for tongue cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:246–50.CrossRefPubMed Obinata K, Ohmori K, Tuchiya K, Nishioka T, Shirato H, Nakamura M. Clinical study of a spacer to help prevent osteoradionecrosis resulting from brachytherapy for tongue cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:246–50.CrossRefPubMed
16.
Zurück zum Zitat Marinello G, Wilson JF, Pierquin B, Barret C, Mazeron JJ. The guide gutter or loop techniques of interstitial implantation and the Paris system of dosimetry. Radiother Oncol. 1985;4:265–73.CrossRefPubMed Marinello G, Wilson JF, Pierquin B, Barret C, Mazeron JJ. The guide gutter or loop techniques of interstitial implantation and the Paris system of dosimetry. Radiother Oncol. 1985;4:265–73.CrossRefPubMed
17.
Zurück zum Zitat Dutreix J. Expression of the dose rate effect in clinical curietherapy. Radiother Oncol. 1989;15:25–37.CrossRefPubMed Dutreix J. Expression of the dose rate effect in clinical curietherapy. Radiother Oncol. 1989;15:25–37.CrossRefPubMed
19.
Zurück zum Zitat Fujita M, Hirokawa Y, Kashiwado K, Akagi Y, Kashimoto K, Kiriu H, et al. Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications. Int J Radiat Oncol Biol Phys. 1999;44:767–75.CrossRefPubMed Fujita M, Hirokawa Y, Kashiwado K, Akagi Y, Kashimoto K, Kiriu H, et al. Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications. Int J Radiat Oncol Biol Phys. 1999;44:767–75.CrossRefPubMed
20.
Zurück zum Zitat Withers HR, Peters LJ, Taylor JM, Owen JB, Morrison WH, Schultheiss TE, et al. Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: patterns of fractionation study of radiobiology. Int J Radiat Oncol Biol Phys. 1995;33:563–8.CrossRefPubMed Withers HR, Peters LJ, Taylor JM, Owen JB, Morrison WH, Schultheiss TE, et al. Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: patterns of fractionation study of radiobiology. Int J Radiat Oncol Biol Phys. 1995;33:563–8.CrossRefPubMed
Metadaten
Titel
Effects of dose rate on early and late complications in low dose rate brachytherapy for mobile tongue carcinoma using 192Ir sources
verfasst von
Atsushi Kaida
Hiroshi Watanabe
Kazuma Toda
Keiko Yuasa-Nakagawa
Ryoichi Yoshimura
Masahiko Miura
Publikationsdatum
09.12.2016
Verlag
Springer Singapore
Erschienen in
Oral Radiology / Ausgabe 3/2017
Print ISSN: 0911-6028
Elektronische ISSN: 1613-9674
DOI
https://doi.org/10.1007/s11282-016-0263-7

Weitere Artikel der Ausgabe 3/2017

Oral Radiology 3/2017 Zur Ausgabe

Parodontalbehandlung verbessert Prognose bei Katheterablation

19.04.2024 Vorhofflimmern Nachrichten

Werden Personen mit Vorhofflimmern in der Blanking-Periode nach einer Katheterablation gegen eine bestehende Parodontitis behandelt, verbessert dies die Erfolgsaussichten. Dafür sprechen die Resultate einer prospektiven Untersuchung.

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

11.04.2024 Endokarditis Nachrichten

Bei welchen Personen eine Antibiotikaprophylaxe zur Prävention einer infektiösen Endokarditis nach invasiven zahnärztlichen Eingriffen sinnvoll ist, wird diskutiert. Neue Daten stehen im Einklang mit den europäischen Leitlinienempfehlungen.

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

08.04.2024 Zahnmedizin Nachrichten

Der Aufbau von Geweben und Organen während der Embryonalentwicklung wird von den Zellen bemerkenswert choreografiert. Für diesen Prozess braucht es spezielle sogenannte „Organisatoren“. In einer aktuellen Veröffentlichung im Fachjournal Nature Cell Biology berichten Forschende durch welchen Vorgang diese Organisatoren im Gewebe entstehen und wie sie dann die Bildung von Zähnen orchestrieren.

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

11.03.2024 Kinderzahnmedizin Nachrichten

Infolge der Umbenennung der Deutschen Gesellschaft für Kinderzahnheilkunde in Deutsche Gesellschaft für Kinderzahnmedizin (DGKiZ) wird deren Mitgliederzeitschrift Oralprophylaxe & Kinderzahnheilkunde in Oralprophylaxe & Kinderzahnmedizin umbenannt. Aus diesem Grunde trägt die erste Ausgabe in 2024 erstmalig den neuen Titel.

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.